Results 1 to 10 of about 15,631 (256)
Tofacitinib for refractory uveitis and scleritis
American Journal of Ophthalmology Case Reports, 2019 Purpose: To report the successful use of tofacitinib in the treatment of refractory uveitis and scleritis. Observations: Two patients, one with scleritis and another with anterior and intermediate uveitis, presented with refractory disease after failure ...
Michael A Paley, Jonathan J Miner
exaly +4 more sources
Frontiers in Immunology, 2023 BackgroundScleritis is a serious inflammatory eye disease that can lead to blindness. The etiology and pathogenesis of scleritis remain unclear, and increasing evidence indicates that some specific genes and proteins are involved.
Feiyue Yan +5 more
doaj +2 more sources
Clinical profile, treatment, and visual outcome of scleritis: A single ophthalmologist experience
Oman Journal of Ophthalmology, 2022 PURPOSE: The purpose of this study was to analyze the clinical profile of patients with scleritis managed by a single ophthalmologist in a tertiary eye care center. METHODS: This was a retrospective analysis of 107 eyes of 96 patients with scleritis from
Kowsigan Magesan +3 more
doaj +2 more sources
Rituximab for non-infectious Uveitis and Scleritis
Journal of Ophthalmic Inflammation and Infection, 2021 Purpose To provide a comprehensive review of rituximab use for the treatment of non-infectious uveitis and scleritis. Methods Review of literature through December 2020.
Caleb C. Ng +2 more
doaj +2 more sources
Health system wide “big data” analysis of rheumatologic conditions and scleritis
BMC Ophthalmology, 2021 Background The development of scleritis in the setting of autoimmune conditions has been well documented. Prior series have assessed the relationship between systemic autoimmune disorders and scleritis only in patients referred for rheumatologic or ...
Meghan K. Berkenstock, Andrew R. Carey
doaj +2 more sources
Arthritis and Rheumatology, 2021 To estimate 22‐year trends in the prevalence and incidence of scleritis, and the associations of scleritis with infectious and immune‐mediated inflammatory diseases (I‐IMIDs) in the UK.
Tasanee Braithwaite +2 more
exaly +2 more sources
Management of noninfectious scleritis
Therapeutic Advances in Ophthalmology, 2022 Scleritis is a manifestation of inflammatory eye disease that involves the sclera. It can be divided into multiple subtypes, including diffuse anterior, nodular anterior, necrotizing, and posterior scleritis. In many cases, scleritis is restricted to the
Ahmad Abdel-Aty +3 more
doaj +2 more sources
BMJ Open Ophthalmology, 2022 Objective To describe the epidemiological and demographic characteristics of scleritis in Colombia.Methods and analysis Population-based study using the national database from the Colombian Ministry of Health, using the International Classification of ...
William Rojas-Carabali +7 more
doaj +2 more sources
PLoS ONE, 2020 BackgroundOcular inflammation causes significant visual morbidity in the United States, yet little is known about the epidemiology of infectious uveitis and scleritis. This study aims to evaluate the epidemiology of infectious uveitis/scleritis employing
Youning Zhang +5 more
doaj +2 more sources
Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives
Journal of Clinical Medicine, 2021 Episcleritis and scleritis are the most common ocular inflammatory manifestation of rheumatoid arthritis. Rheumatoid arthritis (RA) accounts for 8% to 15% of the cases of scleritis, and 2% of patients with RA will develop scleritis.
Veronique Promelle, Vincent Goeb
exaly +2 more sources